文献速递神经创伤脑血管病外科神经重症

创伤性脑损伤合并钝性脑血管损伤的管理模式与结局

Management Patterns and Outcomes After Traumatic Brain Injury With Associated Blunt Cerebrovascular Injury.
PubMed 文献 · Neurosurgery · 2023-09-18

本研究回顾性分析2016年1月至2020年12月在一级创伤中心治疗的323例创伤性脑损伤合并钝性脑血管损伤患者,按Biffl分级评估卒中、功能缺陷和死亡等不良结局的患病率及治疗方式。结果显示,低级别损伤更多使用低剂量(81 mg)阿司匹林(P < .01),但所有级别均以高剂量(150-600 mg)阿司匹林治疗为主(P = .10);低级别损伤患者并发症和卒中显著更少(均P < .01)。与I级相比,II级、III级、IV级损伤的卒中风险OR分别为5.3、12.2、19.6(均P < .05);使用低剂量或高剂量阿司匹林均对死亡率有保护作用(OR均为0.1,P < .05)。

要点

  • 低级别钝性脑血管损伤患者并发症和卒中显著更少(均P < .01)。
  • 与I级相比,II级、III级、IV级损伤卒中风险OR分别为5.3、12.2、19.6(均P < .05)。
  • 使用低剂量或高剂量阿司匹林均对死亡率有保护作用(OR均为0.1,P < .05)。

核心结论

  • 在创伤性脑损伤患者中,钝性脑血管损伤 severity 增加时卒中和相关并发症风险更高;考虑到大多数事件发生在急性窗口期,可能难以减轻高级别损伤相关卒中;晚期卒中稀少提示当前管理策略有助于降低风险。

研究设计与样本

  • 回顾性研究,纳入2016年1月至2020年12月在一级创伤中心治疗的创伤性脑损伤合并钝性脑血管损伤患者323例,进行单因素和多因素分析。

主要发现

  • 323例中,Biffl I级145例、II级91例、III级49例、IV级38例。
  • 低级别损伤更多使用低剂量(81 mg)阿司匹林(P < .01),但所有级别均以高剂量(150-600 mg)阿司匹林治疗为主(P = .10)。
  • 低级别损伤患者并发症显著更少(P < .01),卒中显著更少(P < .01)。
  • 大多数卒中发生在急性时间框架(<24小时),包括10/11(90.9%)的IV级相关卒中。
  • 与I级相比,II级卒中风险OR 5.3、III级OR 12.2、IV级OR 19.6(均P < .05);使用低剂量或高剂量阿司匹林均对死亡率有保护作用(OR均为0.1,P < .05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Although blunt cerebrovascular injuries (BCVIs) are relatively common in patients with traumatic brain injuries (TBIs), uncertainty remains regarding optimal management strategies to prevent neurological complications, morbidity, and mortality. Our objectives were to characterize common care patterns; assess the prevalence of adverse outcomes, including stroke, functional deficits, and death, by BCVI grade; and evaluate therapeutic approaches to treatment in patients with BCVI and TBI. METHODS: Patients with TBI and BCVI treated at our Level I trauma center from January 2016 to December 2020 were identified. Presenting characteristics, treatment, and outcomes were captured for univariate and multivariate analyses. RESULTS: Of 323 patients with BCVI, 145 had Biffl grade I, 91 had grade II, 49 had grade III, and 38 had grade IV injuries. Lower-grade BCVIs were more frequently managed with low-dose (81 mg) aspirin ( P < .01), although all grades were predominantly treated with high-dose (150-600 mg) aspirin ( P = .10). Patients with low-grade BCVIs had significantly fewer complications ( P < .01) and strokes ( P < .01). Most strokes occurred in the acute time frame (<24 hours), including 10/11 (90.9%) grade IV-related strokes. Higher BCVI grade portended elevated risk of stroke (grade II odds ratio [OR] 5.3, grade III OR 12.2, and grade IV OR 19.6 compared with grade I; all P < .05). The use of low- or high-dose aspirin was protective against mortality (both OR 0.1, P < .05). CONCLUSION: In patients with TBI, BCVIs impart greater risk for stroke and other associated morbidities as their severity increases. It may prove difficult to mitigate high-grade BCVI-related stroke, considering most events occur in the acute window. The paucity of late time frame strokes suggest that current management strategies do help mitigate risks.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Findlay MC, Sarriera-Valentin G, Earl ER, et al. Management Patterns and Outcomes After Traumatic Brain Injury With Associated Blunt Cerebrovascular Injury. Neurosurgery. 2023. PMID: 37721436. doi:10.1227/neu.0000000000002688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。